Lumeda Funding & Investors

Lumeda is a biotechnology company that enables practical intraoperative photodynamic therapy for treating lung cancer. The company working closely with the leading medical institutions in the field, Lumeda is developing a solution for a fast, automated intraoperative PDT procedure that offers a step improvement in treatment planning, delivery, and PDT treatment efficacy. Lumeda is developing photonic tools that bring intelligence and control of PDT light delivery to improve its efficacy, ease of use, and treatment planning. The automated PDT light dosimetry solution enables a short, simplified intraoperative PDT (IO-PDT) procedure in NSCLC surgery with improved PDT performance, consistency, and reliability. They applying advanced photonics instrumentation and proprietary software to automate PDT light delivery to targeted tumor and light dosimetry profiles. The company was founded in 2020 and is headquartered in Rocky Hill, CT, USA.